Aurobindo Pharma announced on Tuesday that its ₹800 crore share buyback offer will open on April 23. In a regulatory filing, the company stated that the offer will close on April 29. Earlier, on April 6, the company’s Board of Directors had approved the buyback of a maximum of 5,423,728 fully paid-up equity shares—each with a face value of ₹1—at a price of ₹1,475 per share. According to a PTI report, this buyback will be conducted on a proportionate basis through the tender offer route. The company has set April 17 as the record date, which will serve as the basis for determining which shareholders are eligible to participate in this buyback.
The Objective of the Buyback is to Provide Better Returns to Investors
According to the report and the filing, this buyback constitutes approximately 3.93% (on a standalone basis) and 2.62% (on a consolidated basis) of the company’s total paid-up share capital and free reserves (including securities premium), as reflected in the audited financial statements as of March 31, 2025. In a letter addressed to shareholders, the company stated that the objective of this buyback is to provide better returns to investors. Furthermore, it is expected to lead to an improvement over time in key financial ratios, such as Earnings Per Share (EPS) and Return on Net Worth and Assets. The company also clarified that this buyback will not result in any changes to the management structure or the control of the company.
What is a Share Buyback?
A share buyback is a process in which a company purchases its own shares back from investors. This purchase is typically executed either through a tender offer or via the open market. When a company buys back its shares, the total number of shares available in the market decreases. A direct benefit of this is that the proportionate stake (ownership) of the remaining shareholders increases.
Additionally, the company provides a cash return to its investors, thereby offering them an additional financial benefit. Typically, companies attempt to reward their shareholders and improve their financial ratios—such as Earnings Per Share (EPS)—through share buybacks.
